ADGRF4
gene geneOn this page
Also known as FLJ38076PGR18
Summary
ADGRF4 (adhesion G protein-coupled receptor F4, HGNC:19011) is a protein-coding gene on chromosome 6p12.3, encoding Adhesion G protein-coupled receptor F4 (Q8IZF3). Orphan receptor.
Sequence analysis of this gene suggests that it is encodes a member of the superfamily of G protein-couple receptors. G protein-coupled receptors typically contain seven hydrophobic transmembrane domains, interact with guanine nucleotide binding regulatory proteins, and detect molecules outside the cell and act to transduce these signals into intracellular responses. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 221393 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 102 total
- Druggable target: yes
- MANE Select transcript:
NM_153838
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19011 |
| Approved symbol | ADGRF4 |
| Name | adhesion G protein-coupled receptor F4 |
| Location | 6p12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ38076, PGR18 |
| Ensembl gene | ENSG00000153294 |
| Ensembl biotype | protein_coding |
| OMIM | 614268 |
| Entrez | 221393 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 protein_coding
ENST00000283303, ENST00000327753, ENST00000371220, ENST00000863460, ENST00000863461, ENST00000959108
RefSeq mRNA: 2 — MANE Select: NM_153838
NM_001347855, NM_153838
CCDS: CCDS4922
Canonical transcript exons
ENST00000283303 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001010052 | 47713798 | 47715177 |
| ENSE00001010057 | 47708224 | 47708278 |
| ENSE00001010061 | 47712357 | 47712608 |
| ENSE00001010063 | 47710735 | 47710886 |
| ENSE00001218212 | 47717292 | 47717351 |
| ENSE00001317867 | 47707230 | 47707338 |
| ENSE00001454664 | 47718389 | 47718445 |
| ENSE00001516274 | 47698580 | 47698794 |
| ENSE00002440066 | 47716806 | 47716847 |
| ENSE00003897012 | 47721209 | 47722014 |
Expression profiles
Bgee: expression breadth ubiquitous, 131 present calls, max score 90.90.
FANTOM5 (CAGE): breadth broad, TPM avg 1.7681 / max 77.6997, expressed in 377 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 68171 | 0.9905 | 311 |
| 68173 | 0.4692 | 206 |
| 68170 | 0.1877 | 121 |
| 68172 | 0.1206 | 69 |
Top tissues by expression
230 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of abdomen | UBERON:0001416 | 90.90 | gold quality |
| skin of leg | UBERON:0001511 | 90.39 | gold quality |
| zone of skin | UBERON:0000014 | 88.65 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 85.17 | gold quality |
| esophagus mucosa | UBERON:0002469 | 85.16 | gold quality |
| upper arm skin | UBERON:0004263 | 85.09 | silver quality |
| gingival epithelium | UBERON:0001949 | 81.14 | gold quality |
| penis | UBERON:0000989 | 80.50 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 79.17 | gold quality |
| gingiva | UBERON:0001828 | 76.92 | gold quality |
| right uterine tube | UBERON:0001302 | 75.78 | gold quality |
| amniotic fluid | UBERON:0000173 | 75.13 | gold quality |
| upper leg skin | UBERON:0004262 | 73.28 | gold quality |
| vagina | UBERON:0000996 | 73.08 | gold quality |
| oral cavity | UBERON:0000167 | 69.44 | gold quality |
| skin of hip | UBERON:0001554 | 68.42 | gold quality |
| esophagus | UBERON:0001043 | 66.68 | gold quality |
| stromal cell of endometrium | CL:0002255 | 65.77 | gold quality |
| mammalian vulva | UBERON:0000997 | 65.60 | silver quality |
| islet of Langerhans | UBERON:0000006 | 64.99 | gold quality |
| rectum | UBERON:0001052 | 64.09 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 63.36 | gold quality |
| nipple | UBERON:0002030 | 59.30 | gold quality |
| gall bladder | UBERON:0002110 | 59.21 | gold quality |
| urinary bladder | UBERON:0001255 | 58.58 | gold quality |
| left adrenal gland | UBERON:0001234 | 57.52 | gold quality |
| tonsil | UBERON:0002372 | 57.33 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 56.03 | silver quality |
| pancreatic ductal cell | CL:0002079 | 55.86 | silver quality |
| left adrenal gland cortex | UBERON:0035825 | 55.86 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.70 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
30 targeting ADGRF4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-3617-3P | 99.98 | 67.86 | 918 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-4496 | 99.88 | 68.89 | 2236 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-6132 | 99.60 | 65.83 | 1554 |
| HSA-MIR-6836-5P | 99.60 | 65.62 | 1538 |
| HSA-MIR-7152-5P | 99.60 | 69.33 | 2094 |
| HSA-MIR-4310 | 99.59 | 68.84 | 2527 |
| HSA-MIR-519D-5P | 99.41 | 69.30 | 2057 |
| HSA-MIR-642A-3P | 99.23 | 67.67 | 1258 |
| HSA-MIR-642B-3P | 99.23 | 67.67 | 1258 |
| HSA-MIR-6744-3P | 99.22 | 64.41 | 972 |
| HSA-MIR-4757-5P | 99.12 | 64.51 | 981 |
| HSA-MIR-371A-5P | 99.08 | 66.51 | 1914 |
| HSA-MIR-143-5P | 98.98 | 68.87 | 946 |
| HSA-MIR-5197-3P | 98.71 | 67.05 | 1905 |
| HSA-MIR-9903 | 98.47 | 66.70 | 748 |
| HSA-MIR-615-5P | 98.10 | 63.76 | 591 |
| HSA-MIR-6730-5P | 98.03 | 68.12 | 1299 |
| HSA-MIR-6883-3P | 97.97 | 67.35 | 643 |
| HSA-MIR-3664-3P | 97.85 | 67.62 | 1452 |
| HSA-MIR-4448 | 97.04 | 66.22 | 752 |
| HSA-MIR-34A-3P | 96.80 | 67.70 | 805 |
| HSA-MIR-454-5P | 96.51 | 68.35 | 263 |
| HSA-MIR-5195-5P | 90.84 | 65.09 | 287 |
Literature-anchored findings (GeneRIF, showing 1)
- Clinical significance and functional role of adhesion G-protein-coupled receptors in human pancreatic ductal adenocarcinoma. (PMID:36396823)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Adgrf4 | ENSMUSG00000023918 |
| rattus_norvegicus | Adgrf4 | ENSRNOG00000012535 |
Paralogs (42): CALCR (ENSG00000004948), GIPR (ENSG00000010310), ADGRA2 (ENSG00000020181), CALCRL (ENSG00000064989), GLP2R (ENSG00000065325), ADGRF5 (ENSG00000069122), ADGRL1 (ENSG00000072071), ADCYAP1R1 (ENSG00000078549), SCTR (ENSG00000080293), VIPR2 (ENSG00000106018), CRHR2 (ENSG00000106113), GHRHR (ENSG00000106128), ADGRD1 (ENSG00000111452), GLP1R (ENSG00000112164), ADGRG6 (ENSG00000112414), VIPR1 (ENSG00000114812), ADGRL2 (ENSG00000117114), CRHR1 (ENSG00000120088), ADGRB2 (ENSG00000121753), ADGRE5 (ENSG00000123146), ADGRE2 (ENSG00000127507), ADGRE3 (ENSG00000131355), ADGRB3 (ENSG00000135298), PTH2R (ENSG00000144407), ADGRG7 (ENSG00000144820), ADGRL3 (ENSG00000150471), ADGRA3 (ENSG00000152990), ADGRF1 (ENSG00000153292), ADGRG4 (ENSG00000156920), ADGRG5 (ENSG00000159618), PTH1R (ENSG00000160801), ADGRL4 (ENSG00000162618), EVA1C (ENSG00000166979), ADGRF3 (ENSG00000173567), ADGRG2 (ENSG00000173698), ADGRE1 (ENSG00000174837), ADGRD2 (ENSG00000180264), ADGRB1 (ENSG00000181790), ADGRG3 (ENSG00000182885), ADGRA1 (ENSG00000197177)
Protein
Protein identifiers
Adhesion G protein-coupled receptor F4 — Q8IZF3 (reviewed: Q8IZF3)
Alternative names: G-protein coupled receptor 115, G-protein coupled receptor PGR18
All UniProt accessions (2): Q8IZF3, A0A0C4DFV3
UniProt curated annotations — full annotation on UniProt →
Function. Orphan receptor.
Subcellular location. Membrane.
Miscellaneous. Most adhesion GPCRs undergo autoproteolysis at the GPS region of the GAIN-B domain. ADGRF2 is not autoproteolyzed at the GPS region because of the lack of a consensus catalytic triad sequence within the GAIN-B domain.
Similarity. Belongs to the G-protein coupled receptor 2 family. Adhesion G-protein coupled receptor (ADGR) subfamily.
RefSeq proteins (2): NP_001334784, NP_722580* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000203 | GPS | Conserved_site |
| IPR000832 | GPCR_2_secretin-like | Family |
| IPR008078 | GPCR_2_Ig-hepta-like_rcpt | Family |
| IPR017981 | GPCR_2-like_7TM | Domain |
| IPR046338 | GAIN_dom_sf | Homologous_superfamily |
| IPR051587 | Adhesion_GPCR | Family |
| IPR057244 | GAIN_B | Domain |
Pfam: PF00002, PF01825
UniProt features (41 total): glycosylation site 13, topological domain 8, transmembrane region 7, sequence variant 3, region of interest 2, disulfide bond 2, sequence conflict 2, signal peptide 1, chain 1, domain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IZF3-F1 | 78.70 | 0.39 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 349–376, 364–378
Glycosylation sites (13): 61, 169, 177, 209, 229, 250, 257, 263, 264, 286, 309, 340, 379
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 47 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP, GSE45365_NK_CELL_VS_CD8_TCELL_DN, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, GOZGIT_ESR1_TARGETS_DN, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP, GOBP_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, chr6p12, RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN, AACTTT_UNKNOWN, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, RICKMAN_HEAD_AND_NECK_CANCER_C, GOBP_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN
GO Biological Process (4): cell surface receptor signaling pathway (GO:0007166), G protein-coupled receptor signaling pathway (GO:0007186), adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189), signal transduction (GO:0007165)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), transmembrane signaling receptor activity (GO:0004888), protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| signal transduction | 2 |
| G protein-coupled receptor activity | 1 |
| adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1 |
| adenylate cyclase activator activity | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| signaling receptor activity | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
428 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ADGRF4 | ADGRA1 | Q86SQ6 | 566 |
| ADGRF4 | ADGRA3 | Q8IWK6 | 476 |
| ADGRF4 | ADGRA2 | Q96PE1 | 456 |
| ADGRF4 | C5orf46 | Q6UWT4 | 433 |
| ADGRF4 | WFDC5 | Q8TCV5 | 423 |
| ADGRF4 | ZNF491 | Q8N8L2 | 371 |
| ADGRF4 | OR4C46 | A6NHA9 | 369 |
| ADGRF4 | ZNF530 | Q6P9A1 | 369 |
| ADGRF4 | OR13J1 | Q8NGT2 | 369 |
| ADGRF4 | GPR87 | Q9BY21 | 348 |
| ADGRF4 | ANXA8L1 | Q5VT79 | 338 |
| ADGRF4 | ADGRG4 | Q8IZF6 | 335 |
| ADGRF4 | ADGRG5 | Q8IZF4 | 332 |
| ADGRF4 | PRSS55 | Q6UWB4 | 330 |
| ADGRF4 | SYNGR4 | O95473 | 323 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MEOX2 | ADGRF4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ADGRF4 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (4): GPR115 (Two-hybrid), GPR115 (Proximity Label-MS), LRP1 (Cross-Linking-MS (XL-MS)), GPR115 (Affinity Capture-MS)
ESM2 similar proteins: D4A3T6, E1BPQ3, E9PU17, E9PX95, E9Q4J9, O35659, O60353, O88871, O88917, O88923, O94910, O95490, O95838, O97817, O97827, O97831, P30082, P32082, P32301, P43220, P48960, P49190, P70555, Q02644, Q58Y75, Q59I63, Q5IXF8, Q5T601, Q5U9X3, Q60755, Q6TAC4, Q7SY09, Q80TR1, Q80TS3, Q8IZF3, Q8IZF7, Q8JZZ7, Q8R420, Q8SQA4, Q8VEC3
Diamond homologs: A6QLU6, D4A3T6, E9Q4J9, G5E8Q8, Q2Q421, Q2Q426, Q58Y75, Q5T601, Q6QNK2, Q8IZF2, Q8IZF3, Q8IZF5, Q8IZF7, Q8VEC3, Q9BY15, Q9D2L6, Q9UHX3, Q9WVT0, C6KFA3, O97827, Q7Z7M1, Q80T32, Q80TS3, Q8CJ12, Q8SQA4, Q9HCU4, Q9QYP2, Q9R0M0, Q9Z0M6, Q9Z173, G5ECX0, P48960, Q9ESC1, Q9HAR2, Q14246, Q86SQ3, Q91ZE5, A1Z7G7, B3MFV7, B3N8M1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
102 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 96 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1690 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:47707339:G:GG | donor_gain | 1.0000 |
| 6:47712529:G:GT | donor_gain | 1.0000 |
| 6:47718385:TTAG:T | acceptor_loss | 1.0000 |
| 6:47718387:A:AC | acceptor_loss | 1.0000 |
| 6:47718387:A:AG | acceptor_gain | 1.0000 |
| 6:47718388:G:GA | acceptor_gain | 1.0000 |
| 6:47718388:GA:G | acceptor_gain | 1.0000 |
| 6:47718388:GAAT:G | acceptor_gain | 1.0000 |
| 6:47718443:AATG:A | donor_loss | 1.0000 |
| 6:47718444:ATGT:A | donor_loss | 1.0000 |
| 6:47718445:TG:T | donor_loss | 1.0000 |
| 6:47718446:G:GG | donor_gain | 1.0000 |
| 6:47718446:GTGA:G | donor_loss | 1.0000 |
| 6:47718447:TGA:T | donor_loss | 1.0000 |
| 6:47718448:GAG:G | donor_loss | 1.0000 |
| 6:47698795:G:GG | donor_gain | 0.9900 |
| 6:47699444:G:T | donor_gain | 0.9900 |
| 6:47707335:AAAAG:A | donor_loss | 0.9900 |
| 6:47707336:AAAGT:A | donor_loss | 0.9900 |
| 6:47707337:AAG:A | donor_loss | 0.9900 |
| 6:47707338:AG:A | donor_loss | 0.9900 |
| 6:47707339:GTAAG:G | donor_loss | 0.9900 |
| 6:47707340:TAA:T | donor_loss | 0.9900 |
| 6:47707341:AAG:A | donor_loss | 0.9900 |
| 6:47712463:G:GG | donor_gain | 0.9900 |
| 6:47712773:TTTTC:T | donor_gain | 0.9900 |
| 6:47713792:TTGCA:T | acceptor_loss | 0.9900 |
| 6:47713794:GCA:G | acceptor_loss | 0.9900 |
| 6:47713796:A:AG | acceptor_gain | 0.9900 |
| 6:47713797:G:GC | acceptor_loss | 0.9900 |
AlphaMissense
4625 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:47714322:G:C | W359C | 0.997 |
| 6:47714322:G:T | W359C | 0.997 |
| 6:47714488:A:C | S415R | 0.994 |
| 6:47714490:C:A | S415R | 0.994 |
| 6:47714490:C:G | S415R | 0.994 |
| 6:47714320:T:A | W359R | 0.992 |
| 6:47714320:T:C | W359R | 0.992 |
| 6:47714301:G:C | W352C | 0.988 |
| 6:47714301:G:T | W352C | 0.988 |
| 6:47716806:G:C | G645R | 0.988 |
| 6:47713851:G:C | W202C | 0.986 |
| 6:47713851:G:T | W202C | 0.986 |
| 6:47714580:T:A | N445K | 0.985 |
| 6:47714580:T:G | N445K | 0.985 |
| 6:47715154:T:C | F637L | 0.984 |
| 6:47715156:T:A | F637L | 0.984 |
| 6:47715156:T:G | F637L | 0.984 |
| 6:47714299:T:A | W352R | 0.983 |
| 6:47714299:T:C | W352R | 0.983 |
| 6:47713849:T:A | W202R | 0.978 |
| 6:47713849:T:C | W202R | 0.978 |
| 6:47714404:T:C | F387L | 0.978 |
| 6:47714406:T:A | F387L | 0.978 |
| 6:47714406:T:G | F387L | 0.978 |
| 6:47715097:T:A | W618R | 0.978 |
| 6:47715097:T:C | W618R | 0.978 |
| 6:47714290:T:A | C349S | 0.976 |
| 6:47714291:G:C | C349S | 0.976 |
| 6:47710854:T:A | C90S | 0.974 |
| 6:47710855:G:C | C90S | 0.974 |
dbSNP variants (sampled 300 via entrez): RS1000004754 (6:47717110 A>C), RS1000023765 (6:47701980 A>G,T), RS1000256603 (6:47696717 C>T), RS1000281286 (6:47696667 C>T), RS1000288839 (6:47707590 C>T), RS1000359961 (6:47712388 C>A), RS1000640845 (6:47707395 G>A), RS1000914071 (6:47707892 G>A), RS1000968520 (6:47713106 G>C), RS1001026078 (6:47703575 C>G,T), RS1001090606 (6:47697480 C>T), RS1001271740 (6:47720607 C>T), RS1001418565 (6:47713995 T>C), RS1001635206 (6:47710874 A>G), RS1001650287 (6:47719365 G>A)
Disease associations
OMIM: gene MIM:614268 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523889 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Adhesion Class GPCRs
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 2 |
| (+)-JQ1 compound | decreases expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases methylation, increases expression | 2 |
| Tobacco Smoke Pollution | affects expression, increases expression | 2 |
| Aflatoxin B1 | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| methyleugenol | increases expression | 1 |
| propionaldehyde | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| NSC 689534 | affects binding, increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Calcitriol | increases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Copper | affects binding, increases expression | 1 |
| Demecolcine | increases expression | 1 |
| Endosulfan | decreases expression | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| N-Nitrosopyrrolidine | increases expression | 1 |
| Nickel | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Vincristine | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4883399 | Binding | PRESTO-Tango GPCRome screening (GPR115) | Data for DCP probe UCSF924 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.